PDB Short entry for 2IEJ HEADER TRANSFERASE 19-SEP-06 2IEJ TITLE HUMAN PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH INHIBITOR COMPOUND TITLE 2 STN-48 AND FPP ANALOG AT 1.8A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN FARNESYLTRANSFERASE/GERANYLGERANYLTRANSFERASE TYPE COMPND 3 I ALPHA SUBUNIT; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: CAAX FARNESYLTRANSFERASE ALPHA SUBUNIT, RAS PROTEINS COMPND 6 PRENYLTRANSFERASE ALPHA, FTASE-ALPHA, TYPE I PROTEIN GERANYL- COMPND 7 GERANYLTRANSFERASE ALPHA SUBUNIT, GGTASE-I-ALPHA; COMPND 8 EC: 2.5.1.58, 2.5.1.59; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: PROTEIN FARNESYLTRANSFERASE SUBUNIT BETA; COMPND 12 CHAIN: B; COMPND 13 SYNONYM: CAAX FARNESYLTRANSFERASE SUBUNIT BETA, RAS PROTEINS COMPND 14 PRENYLTRANSFERASE BETA, FTASE-BETA; COMPND 15 EC: 2.5.1.58; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FNTA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PAK-41; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: FNTB; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21-DE3; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PAK-41 KEYWDS FTASE, FARNESYLTRANSFERASE, FARNESYL TRANSFERASE, CAAX, RAS, CANCER, KEYWDS 2 TUMOR REGRESSION, STN-48, PROTEIN PRENYLATION, LIPID MODIFICATION, KEYWDS 3 PLASMODIUM, FALCIPARUM, MALARIA, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.A.HAST,L.S.BEESE REVDAT 5 21-FEB-24 2IEJ 1 HETSYN REVDAT 4 29-JUL-20 2IEJ 1 COMPND REMARK SEQADV HET REVDAT 4 2 1 HETNAM FORMUL LINK SITE REVDAT 4 3 1 ATOM REVDAT 3 24-FEB-09 2IEJ 1 VERSN REVDAT 2 06-FEB-07 2IEJ 1 JRNL REVDAT 1 23-JAN-07 2IEJ 0 JRNL AUTH R.T.EASTMAN,J.WHITE,O.HUCKE,K.YOKOYAMA,C.L.VERLINDE, JRNL AUTH 2 M.A.HAST,L.S.BEESE,M.H.GELB,P.K.RATHOD,W.C.VAN VOORHIS JRNL TITL RESISTANCE MUTATIONS AT THE LIPID SUBSTRATE BINDING SITE OF JRNL TITL 2 PLASMODIUM FALCIPARUM PROTEIN FARNESYLTRANSFERASE. JRNL REF MOL.BIOCHEM.PARASITOL. V. 152 66 2007 JRNL REFN ISSN 0166-6851 JRNL PMID 17208314 JRNL DOI 10.1016/J.MOLBIOPARA.2006.11.012 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.69 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 107537 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.188 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5376 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6778 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2300 REMARK 3 BIN FREE R VALUE SET COUNT : 357 REMARK 3 BIN FREE R VALUE : 0.2750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5911 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 106 REMARK 3 SOLVENT ATOMS : 708 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.75 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.089 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.088 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.058 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.856 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.958 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6178 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8395 ; 1.294 ; 1.965 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 725 ; 5.095 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 314 ;34.465 ;24.108 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1020 ;13.237 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 40 ;17.430 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 890 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4791 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 3114 ; 0.197 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4253 ; 0.307 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 594 ; 0.139 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 2 ; 0.035 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 84 ; 0.187 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 34 ; 0.170 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3738 ; 0.930 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5859 ; 1.455 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2823 ; 2.269 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2535 ; 3.609 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2IEJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-SEP-06. REMARK 100 THE DEPOSITION ID IS D_1000039484. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 107537 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.7200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.27100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLIZED VIA HANGING DROP AGAINST REMARK 280 WELL SOLUTION CONTAINING 300 MM AMMONIUM ACETATE PH 5.2, 12% PEG REMARK 280 8K , VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 21.55367 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.10733 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 32.33050 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 53.88417 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 10.77683 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS ONE BIOLOGICAL ASSEMBLY. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -65.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 GLU A 5 REMARK 465 GLY A 6 REMARK 465 VAL A 7 REMARK 465 GLY A 8 REMARK 465 GLU A 9 REMARK 465 ALA A 10 REMARK 465 ALA A 11 REMARK 465 GLN A 12 REMARK 465 GLY A 13 REMARK 465 GLY A 14 REMARK 465 GLU A 15 REMARK 465 PRO A 16 REMARK 465 GLY A 17 REMARK 465 GLN A 18 REMARK 465 PRO A 19 REMARK 465 ALA A 20 REMARK 465 GLN A 21 REMARK 465 PRO A 22 REMARK 465 PRO A 23 REMARK 465 PRO A 24 REMARK 465 GLN A 25 REMARK 465 PRO A 26 REMARK 465 HIS A 27 REMARK 465 PRO A 28 REMARK 465 PRO A 29 REMARK 465 PRO A 30 REMARK 465 PRO A 31 REMARK 465 GLN A 32 REMARK 465 GLN A 33 REMARK 465 GLN A 34 REMARK 465 HIS A 35 REMARK 465 LYS A 36 REMARK 465 GLU A 37 REMARK 465 GLU A 38 REMARK 465 MET A 39 REMARK 465 ALA A 40 REMARK 465 ALA A 41 REMARK 465 GLU A 42 REMARK 465 ALA A 43 REMARK 465 GLY A 44 REMARK 465 GLU A 45 REMARK 465 ALA A 46 REMARK 465 VAL A 47 REMARK 465 ALA A 48 REMARK 465 SER A 49 REMARK 465 PRO A 50 REMARK 465 MET A 51 REMARK 465 ASP A 52 REMARK 465 ASP A 53 REMARK 465 GLY A 54 REMARK 465 GLU A 370 REMARK 465 ASN A 371 REMARK 465 ASP A 372 REMARK 465 SER A 373 REMARK 465 PRO A 374 REMARK 465 THR A 375 REMARK 465 ASN A 376 REMARK 465 VAL A 377 REMARK 465 GLN A 378 REMARK 465 GLN A 379 REMARK 465 GLU A 380 REMARK 465 GLU A 381 REMARK 465 PHE A 382 REMARK 465 MET B 501 REMARK 465 ALA B 502 REMARK 465 SER B 503 REMARK 465 PRO B 504 REMARK 465 SER B 505 REMARK 465 SER B 506 REMARK 465 PHE B 507 REMARK 465 THR B 508 REMARK 465 TYR B 509 REMARK 465 TYR B 510 REMARK 465 CYS B 511 REMARK 465 PRO B 512 REMARK 465 PRO B 513 REMARK 465 SER B 514 REMARK 465 GLU B 925 REMARK 465 LEU B 926 REMARK 465 LYS B 927 REMARK 465 ASP B 928 REMARK 465 GLU B 929 REMARK 465 THR B 930 REMARK 465 SER B 931 REMARK 465 ALA B 932 REMARK 465 GLU B 933 REMARK 465 PRO B 934 REMARK 465 ALA B 935 REMARK 465 THR B 936 REMARK 465 ASP B 937 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 88 50.53 34.28 REMARK 500 LYS A 164 70.10 -105.04 REMARK 500 LEU A 215 56.68 -102.84 REMARK 500 THR A 247 -89.45 -111.30 REMARK 500 GLU A 347 -53.46 -129.74 REMARK 500 ASP A 349 50.24 -150.36 REMARK 500 ASN B 565 -116.57 47.95 REMARK 500 ARG B 587 -94.06 -101.93 REMARK 500 ASP B 820 109.82 -50.53 REMARK 500 SER B 826 -20.47 -141.86 REMARK 500 MET B 829 49.66 -84.55 REMARK 500 SER B 878 113.94 -160.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 939 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 797 OD1 REMARK 620 2 ASP B 797 OD2 57.4 REMARK 620 3 CYS B 799 SG 103.4 89.3 REMARK 620 4 HIS B 862 NE2 127.9 90.8 117.6 REMARK 620 5 S48 B 943 NAW 95.3 149.5 112.1 97.5 REMARK 620 N 1 2 3 4 DBREF 2IEJ A 1 379 UNP P49354 PFTA_HUMAN 1 379 DBREF 2IEJ B 501 937 UNP P49356 PFTB_HUMAN 1 437 SEQADV 2IEJ GLU A 380 UNP P49354 CLONING ARTIFACT SEQADV 2IEJ GLU A 381 UNP P49354 CLONING ARTIFACT SEQADV 2IEJ PHE A 382 UNP P49354 CLONING ARTIFACT SEQRES 1 A 382 MET ALA ALA THR GLU GLY VAL GLY GLU ALA ALA GLN GLY SEQRES 2 A 382 GLY GLU PRO GLY GLN PRO ALA GLN PRO PRO PRO GLN PRO SEQRES 3 A 382 HIS PRO PRO PRO PRO GLN GLN GLN HIS LYS GLU GLU MET SEQRES 4 A 382 ALA ALA GLU ALA GLY GLU ALA VAL ALA SER PRO MET ASP SEQRES 5 A 382 ASP GLY PHE VAL SER LEU ASP SER PRO SER TYR VAL LEU SEQRES 6 A 382 TYR ARG ASP ARG ALA GLU TRP ALA ASP ILE ASP PRO VAL SEQRES 7 A 382 PRO GLN ASN ASP GLY PRO ASN PRO VAL VAL GLN ILE ILE SEQRES 8 A 382 TYR SER ASP LYS PHE ARG ASP VAL TYR ASP TYR PHE ARG SEQRES 9 A 382 ALA VAL LEU GLN ARG ASP GLU ARG SER GLU ARG ALA PHE SEQRES 10 A 382 LYS LEU THR ARG ASP ALA ILE GLU LEU ASN ALA ALA ASN SEQRES 11 A 382 TYR THR VAL TRP HIS PHE ARG ARG VAL LEU LEU LYS SER SEQRES 12 A 382 LEU GLN LYS ASP LEU HIS GLU GLU MET ASN TYR ILE THR SEQRES 13 A 382 ALA ILE ILE GLU GLU GLN PRO LYS ASN TYR GLN VAL TRP SEQRES 14 A 382 HIS HIS ARG ARG VAL LEU VAL GLU TRP LEU ARG ASP PRO SEQRES 15 A 382 SER GLN GLU LEU GLU PHE ILE ALA ASP ILE LEU ASN GLN SEQRES 16 A 382 ASP ALA LYS ASN TYR HIS ALA TRP GLN HIS ARG GLN TRP SEQRES 17 A 382 VAL ILE GLN GLU PHE LYS LEU TRP ASP ASN GLU LEU GLN SEQRES 18 A 382 TYR VAL ASP GLN LEU LEU LYS GLU ASP VAL ARG ASN ASN SEQRES 19 A 382 SER VAL TRP ASN GLN ARG TYR PHE VAL ILE SER ASN THR SEQRES 20 A 382 THR GLY TYR ASN ASP ARG ALA VAL LEU GLU ARG GLU VAL SEQRES 21 A 382 GLN TYR THR LEU GLU MET ILE LYS LEU VAL PRO HIS ASN SEQRES 22 A 382 GLU SER ALA TRP ASN TYR LEU LYS GLY ILE LEU GLN ASP SEQRES 23 A 382 ARG GLY LEU SER LYS TYR PRO ASN LEU LEU ASN GLN LEU SEQRES 24 A 382 LEU ASP LEU GLN PRO SER HIS SER SER PRO TYR LEU ILE SEQRES 25 A 382 ALA PHE LEU VAL ASP ILE TYR GLU ASP MET LEU GLU ASN SEQRES 26 A 382 GLN CYS ASP ASN LYS GLU ASP ILE LEU ASN LYS ALA LEU SEQRES 27 A 382 GLU LEU CYS GLU ILE LEU ALA LYS GLU LYS ASP THR ILE SEQRES 28 A 382 ARG LYS GLU TYR TRP ARG TYR ILE GLY ARG SER LEU GLN SEQRES 29 A 382 SER LYS HIS SER THR GLU ASN ASP SER PRO THR ASN VAL SEQRES 30 A 382 GLN GLN GLU GLU PHE SEQRES 1 B 437 MET ALA SER PRO SER SER PHE THR TYR TYR CYS PRO PRO SEQRES 2 B 437 SER SER SER PRO VAL TRP SER GLU PRO LEU TYR SER LEU SEQRES 3 B 437 ARG PRO GLU HIS ALA ARG GLU ARG LEU GLN ASP ASP SER SEQRES 4 B 437 VAL GLU THR VAL THR SER ILE GLU GLN ALA LYS VAL GLU SEQRES 5 B 437 GLU LYS ILE GLN GLU VAL PHE SER SER TYR LYS PHE ASN SEQRES 6 B 437 HIS LEU VAL PRO ARG LEU VAL LEU GLN ARG GLU LYS HIS SEQRES 7 B 437 PHE HIS TYR LEU LYS ARG GLY LEU ARG GLN LEU THR ASP SEQRES 8 B 437 ALA TYR GLU CYS LEU ASP ALA SER ARG PRO TRP LEU CYS SEQRES 9 B 437 TYR TRP ILE LEU HIS SER LEU GLU LEU LEU ASP GLU PRO SEQRES 10 B 437 ILE PRO GLN ILE VAL ALA THR ASP VAL CYS GLN PHE LEU SEQRES 11 B 437 GLU LEU CYS GLN SER PRO GLU GLY GLY PHE GLY GLY GLY SEQRES 12 B 437 PRO GLY GLN TYR PRO HIS LEU ALA PRO THR TYR ALA ALA SEQRES 13 B 437 VAL ASN ALA LEU CYS ILE ILE GLY THR GLU GLU ALA TYR SEQRES 14 B 437 ASP ILE ILE ASN ARG GLU LYS LEU LEU GLN TYR LEU TYR SEQRES 15 B 437 SER LEU LYS GLN PRO ASP GLY SER PHE LEU MET HIS VAL SEQRES 16 B 437 GLY GLY GLU VAL ASP VAL ARG SER ALA TYR CYS ALA ALA SEQRES 17 B 437 SER VAL ALA SER LEU THR ASN ILE ILE THR PRO ASP LEU SEQRES 18 B 437 PHE GLU GLY THR ALA GLU TRP ILE ALA ARG CYS GLN ASN SEQRES 19 B 437 TRP GLU GLY GLY ILE GLY GLY VAL PRO GLY MET GLU ALA SEQRES 20 B 437 HIS GLY GLY TYR THR PHE CYS GLY LEU ALA ALA LEU VAL SEQRES 21 B 437 ILE LEU LYS ARG GLU ARG SER LEU ASN LEU LYS SER LEU SEQRES 22 B 437 LEU GLN TRP VAL THR SER ARG GLN MET ARG PHE GLU GLY SEQRES 23 B 437 GLY PHE GLN GLY ARG CYS ASN LYS LEU VAL ASP GLY CYS SEQRES 24 B 437 TYR SER PHE TRP GLN ALA GLY LEU LEU PRO LEU LEU HIS SEQRES 25 B 437 ARG ALA LEU HIS ALA GLN GLY ASP PRO ALA LEU SER MET SEQRES 26 B 437 SER HIS TRP MET PHE HIS GLN GLN ALA LEU GLN GLU TYR SEQRES 27 B 437 ILE LEU MET CYS CYS GLN CYS PRO ALA GLY GLY LEU LEU SEQRES 28 B 437 ASP LYS PRO GLY LYS SER ARG ASP PHE TYR HIS THR CYS SEQRES 29 B 437 TYR CYS LEU SER GLY LEU SER ILE ALA GLN HIS PHE GLY SEQRES 30 B 437 SER GLY ALA MET LEU HIS ASP VAL VAL LEU GLY VAL PRO SEQRES 31 B 437 GLU ASN ALA LEU GLN PRO THR HIS PRO VAL TYR ASN ILE SEQRES 32 B 437 GLY PRO ASP LYS VAL ILE GLN ALA THR THR TYR PHE LEU SEQRES 33 B 437 GLN LYS PRO VAL PRO GLY PHE GLU GLU LEU LYS ASP GLU SEQRES 34 B 437 THR SER ALA GLU PRO ALA THR ASP HET GLC C 1 11 HET FRU C 2 12 HET ACT A 903 4 HET ACT A 905 4 HET ZN B 939 1 HET ACT B 940 4 HET ACT B 941 4 HET ACT B 942 4 HET S48 B 943 38 HET FII B 944 24 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM FRU BETA-D-FRUCTOFURANOSE HETNAM ACT ACETATE ION HETNAM ZN ZINC ION HETNAM S48 METHYL N-{(3S)-1-[(1-METHYL-1H-IMIDAZOL-5-YL)METHYL]-6- HETNAM 2 S48 PHENYL-1,2,3,4-TETRAHYDROQUINOLIN-3-YL}-N-[(1-METHYL- HETNAM 3 S48 1H-IMIDAZOL-4-YL)SULFONYL]GLYCINATE HETNAM FII [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)- HETNAM 2 FII METHYL]-PHOSPHONIC ACID HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN FRU BETA-D-FRUCTOSE; D-FRUCTOSE; FRUCTOSE HETSYN FII FPP ANALOG FORMUL 3 GLC C6 H12 O6 FORMUL 3 FRU C6 H12 O6 FORMUL 4 ACT 5(C2 H3 O2 1-) FORMUL 6 ZN ZN 2+ FORMUL 10 S48 C27 H30 N6 O4 S FORMUL 11 FII C17 H30 N O5 P FORMUL 12 HOH *708(H2 O) HELIX 1 1 LEU A 65 ALA A 73 5 9 HELIX 2 2 SER A 93 ASP A 110 1 18 HELIX 3 3 SER A 113 ASN A 127 1 15 HELIX 4 4 ASN A 130 LEU A 144 1 15 HELIX 5 5 ASP A 147 GLN A 162 1 16 HELIX 6 6 ASN A 165 ARG A 180 1 16 HELIX 7 7 GLN A 184 ASP A 196 1 13 HELIX 8 8 ASN A 199 LYS A 214 1 16 HELIX 9 9 ASN A 218 ASP A 230 1 13 HELIX 10 10 ASN A 233 THR A 247 1 15 HELIX 11 11 ASP A 252 VAL A 270 1 19 HELIX 12 12 ASN A 273 GLN A 285 1 13 HELIX 13 13 GLY A 288 LYS A 291 5 4 HELIX 14 14 TYR A 292 GLN A 303 1 12 HELIX 15 15 SER A 308 ASN A 325 1 18 HELIX 16 16 ASN A 329 GLU A 347 1 19 HELIX 17 17 ASP A 349 ILE A 351 5 3 HELIX 18 18 ARG A 352 SER A 368 1 17 HELIX 19 19 LEU B 523 ARG B 534 5 12 HELIX 20 20 THR B 542 SER B 561 1 20 HELIX 21 21 GLN B 574 LEU B 586 1 13 HELIX 22 22 THR B 590 ASP B 597 5 8 HELIX 23 23 SER B 599 LEU B 614 1 16 HELIX 24 24 PRO B 619 GLN B 634 1 16 HELIX 25 25 HIS B 649 GLY B 664 1 16 HELIX 26 26 THR B 665 ILE B 672 1 8 HELIX 27 27 ASN B 673 LYS B 685 1 13 HELIX 28 28 ASP B 700 THR B 714 1 15 HELIX 29 29 GLY B 724 GLN B 733 1 10 HELIX 30 30 HIS B 748 LYS B 763 1 16 HELIX 31 31 ARG B 764 LEU B 768 5 5 HELIX 32 32 ASN B 769 ARG B 780 1 12 HELIX 33 33 CYS B 799 GLN B 804 1 6 HELIX 34 34 GLY B 806 GLN B 818 1 13 HELIX 35 35 HIS B 831 CYS B 843 1 13 HELIX 36 36 ASP B 859 GLN B 874 1 16 HELIX 37 37 VAL B 889 ALA B 893 5 5 HELIX 38 38 GLY B 904 GLN B 917 1 14 SHEET 1 A 2 GLN A 89 ILE A 90 0 SHEET 2 A 2 GLN B 588 LEU B 589 1 O LEU B 589 N GLN A 89 SHEET 1 B 2 HIS B 875 SER B 878 0 SHEET 2 B 2 MET B 881 ASP B 884 -1 O MET B 881 N SER B 878 LINK C1 GLC C 1 O2 FRU C 2 1555 1555 1.42 LINK OD1 ASP B 797 ZN ZN B 939 1555 1555 1.98 LINK OD2 ASP B 797 ZN ZN B 939 1555 1555 2.45 LINK SG CYS B 799 ZN ZN B 939 1555 1555 2.37 LINK NE2 HIS B 862 ZN ZN B 939 1555 1555 2.04 LINK ZN ZN B 939 NAW S48 B 943 1555 1555 2.15 CRYST1 178.253 178.253 64.661 90.00 90.00 120.00 P 61 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005610 0.003239 0.000000 0.00000 SCALE2 0.000000 0.006478 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015465 0.00000